What Is Cannabinoid Hyperemesis Syndrome?
Cannabinoid hyperemesis syndrome involves recurring vomiting and abdominal pain. Learn why medical assessment and stopping cannabis matter.
Cannabinoid hyperemesis syndrome (CHS) involves recurring nausea, vomiting, and abdominal pain associated with long-term, heavy cannabis use. It often needs medical attention. Temporary comfort from a hot shower does not mean the condition has resolved, and symptoms alone cannot establish a diagnosis online. Source: National Institute on Drug Abuse (NIDA).
When cannabis has been part of your life for a long time, connecting it with stomach symptoms can feel confusing. You may know that certain cannabis-related medicines treat nausea in specific medical settings. Yet cannabis can also be associated with a recurring vomiting syndrome. The useful distinction is between understanding this possibility and deciding that it explains your symptoms. A medical evaluation addresses the current illness; a longer-term plan addresses cannabis use if CHS is identified. You do not need to settle the diagnosis yourself before seeking help. NIDA explains both cannabis-related nausea treatment and CHS.
What does cannabinoid hyperemesis syndrome mean?
CHS is a syndrome involving nausea, vomiting, and abdominal pain after long-term, heavy cannabis use, according to NIDA's cannabis resource. It is a specific medical concern, distinct from broader questions about THC, CBD, and cannabis product claims or deciding what substance-use care might fit your needs.
A syndrome is a group of symptoms that occur together in a recognizable pattern. In CHS, the central symptoms are gastrointestinal, meaning they involve the digestive system. The term does not mean that every stomach problem in someone who uses cannabis has the same cause. It names one possibility that belongs in a medical evaluation.
The main features described by NIDA are:
- Nausea: feeling sick to your stomach or as though you may vomit.
- Vomiting: episodes that can recur rather than being limited to one isolated illness.
- Abdominal pain: pain in the belly occurring in the context of long-term, heavy cannabis use.
NIDA states that CHS can recur and often requires medical attention. Recognizing that pattern is a reason to get care, not a way to rule out other explanations. A familiar episode still deserves attention when it returns.
CHS also differs from cannabis withdrawal. Withdrawal can occur after stopping or significantly reducing heavy or long-term cannabis use. Its possible symptoms include irritability, anxiety, sleep changes, reduced appetite, and abdominal pain. CHS centers on the nausea, vomiting, and abdominal pain syndrome associated with long-term, heavy use. Because some symptoms overlap, the timing and overall pattern matter. NIDA describes CHS and withdrawal separately.
Neither term should become a label you must prove before receiving help. You can seek medical attention for vomiting without knowing its cause. You can also seek support for cannabis use without first deciding that you have a substance use disorder.
Why can cannabis be overlooked when nausea is the main concern?
Cannabis can be overlooked because its connection with nausea is not always intuitive. Some cannabis-related medicines have approved uses for chemotherapy-related nausea and vomiting, while long-term, heavy cannabis use can be associated with CHS. Understanding what cannabis product claims do and do not establish helps keep those different facts separate. NIDA explains these distinct uses and risks.
A treatment used for a particular condition does not establish that all related products will help every kind of nausea. The medical setting, product, reason for treatment, and person receiving it matter. Knowing that a cannabis-related medicine has a legitimate use does not rule out a harmful effect from cannabis in another situation.
The reverse is also true: learning about CHS does not mean that all nausea experienced by people who use cannabis is CHS. Both shortcuts can get in the way of care. One dismisses cannabis as a possible contributor; the other assumes it is the entire explanation before a clinician has evaluated the illness.
Product names and familiarity do not settle the question. NIDA notes that cannabis effects vary with factors such as the amount used, THC strength, ingredients, how a product is consumed, other drugs taken, and underlying health conditions. Those differences are reasons for an individual evaluation rather than a conclusion based on a package label or someone else's experience. Source: NIDA's overview of cannabis effects.
If you have used cannabis for stress, sleep, or another concern, the possibility of a related health problem may also raise a practical worry: what will replace the role cannabis has been playing? That concern deserves attention alongside the stomach symptoms. It does not need to be answered before medical care begins. Immediate evaluation and longer-term support have different jobs, and both can be part of the same plan.
Why is recurrent vomiting a medical issue rather than an online diagnosis?
Recurrent vomiting needs medical evaluation because recognizing a possible CHS pattern does not establish its cause or the care needed now. NIDA says CHS often requires medical attention. The distinction between emergency care and routine outpatient treatment matters more than finding a matching symptom description online.
An online explanation cannot examine you or determine why you are vomiting. It also cannot establish that a previous explanation still fits a new episode. Cannabis history is relevant medical information, but it should not replace an assessment of the symptoms themselves.
A clinician can consider the pattern of illness alongside cannabis use and other health information. The aim is not to make you defend or apologize for using cannabis. It is to understand what could be contributing and what care is appropriate. NIDA's broader treatment guidance emphasizes that care should address a person's substance use together with related medical, mental-health, and social needs. Source: NIDA, Treatment and Recovery.
The following distinctions can help you understand why a single clue is not enough:
| What you notice | What it may tell you | What it does not establish |
|---|---|---|
| Nausea, vomiting, and belly pain with long-term, heavy cannabis use | CHS is a possibility worth medical attention. | That cannabis is definitely the cause of this episode. |
| Similar symptoms return | Recurrence is consistent with NIDA's description of CHS. | That the episode is harmless because it feels familiar. |
| A hot shower briefly eases discomfort | Temporary relief can occur in people with CHS. | That the syndrome has resolved or medical care is unnecessary. |
| Symptoms occur after reducing or stopping cannabis | Withdrawal may also need consideration. | That every symptom after stopping is withdrawal rather than another medical concern. |
These are educational distinctions, not diagnostic rules. NIDA provides the underlying descriptions of CHS, temporary hot-water relief, and cannabis withdrawal.
How is temporary symptom relief different from resolving the syndrome?
Temporary relief changes how you feel for a time; resolving CHS requires stopping cannabis completely, according to NIDA. That distinction matters when interpreting cannabis product claims or comparing CHS with symptoms associated with stopping cannabis. Comfort, diagnosis, and lasting resolution are different questions.
NIDA notes that people with CHS sometimes use hot showers or baths to relieve symptoms temporarily. The word temporarily is central. Feeling better during or after a shower does not show that the underlying syndrome has ended. It also does not prove that CHS caused the symptoms in the first place.
For the same reason, a period of feeling well between episodes should not be treated as proof that the issue is over. CHS can recur. A longer-term plan needs to account for that possibility rather than focusing only on getting through the current discomfort. Source: NIDA's CHS explanation.
Switching products, changing the way cannabis is consumed, or choosing a product marketed as gentler should not be presented as an established way to resolve CHS. NIDA's stated condition for resolution is complete cannabis cessation. Its CHS guidance does not offer a product substitution as an alternative. That is different from saying that every product carries identical risks or that every person will have the same experience.
This information can be hard to hear if cannabis has felt useful in another part of your life. The medical concern and the reason you use cannabis can both be taken seriously. Addressing the syndrome does not require dismissing anxiety, poor sleep, distress, or other needs that may also deserve care.
No fixed recovery deadline should be promised from this overview. Medical follow-up is the place to assess ongoing symptoms and the longer-term course. Continuing symptoms should not be dismissed merely because you have already changed your cannabis use.
How can cannabis-use treatment support the longer-term plan?
Cannabis-use treatment can help address difficulty stopping and the patterns surrounding use, while medical care addresses suspected CHS and current physical symptoms. Women's Recovery's outpatient programs address mental health and trauma, with substance-use concerns included when relevant. That support does not replace medical evaluation for recurrent vomiting.
If stopping feels difficult, that is a reason for support rather than a character judgment. It also does not establish a diagnosis by itself. NIDA describes cannabis use disorder as a pattern involving clinically significant distress or problems, assessed through several possible symptoms. A clinician considers the full pattern rather than drawing a conclusion from one struggle. Source: NIDA's cannabis use disorder overview.
Behavioral treatment works on actions, thoughts, motivation, and situations connected with substance use. NIDA identifies several behavioral approaches that can be effective for cannabis use disorder:
- Cognitive behavioral therapy: helps people recognize situations linked with use and build ways to respond without returning to the same behavior.
- Motivational enhancement therapy: works with a person's readiness and reasons for changing substance use.
- Contingency management: uses positive reinforcement for specific treatment behaviors, such as attending care or meeting agreed substance-use goals.
NIDA identifies these approaches for cannabis use disorder, and its treatment overview explains their purposes. This is general treatment education, not a claim that every approach is available in every Women's Recovery program.
A useful longer-term plan also takes other needs seriously. If cannabis use has become tied to evenings, relationships, or managing distress, treatment can address those patterns rather than treating stopping as an isolated act of willpower. NIDA recommends care tailored to the person's substance use and related medical, mental-health, and social problems.
Women's Recovery provides outpatient care in Denver, CO, including Partial Hospitalization Program (PHP), Intensive Outpatient Program (IOP), and outpatient care based on assessment. It does not provide onsite detox, residential treatment, or inpatient services. The right next step depends on current needs, and an outpatient program should not be treated as acute gastrointestinal care.
Once immediate medical needs are addressed, you can explore the current programs or contact Women's Recovery at 833.754.0554. You do not need to choose a program or arrive with a substance-use diagnosis before reaching out.
Frequently asked questions
Does every episode of vomiting in a cannabis user establish CHS?
No. Nausea, vomiting, and abdominal pain can raise concern about CHS in the context of long-term, heavy cannabis use, but they do not establish the diagnosis online. Medical evaluation is needed to assess the illness and consider its cause. Knowing about CHS should support seeking care, not replace it.
Can CHS recur?
Yes. NIDA describes CHS as a condition that can recur and often requires medical attention. A period of feeling better does not establish that the problem has permanently ended. NIDA states that CHS resolves only when cannabis use stops completely. Recurring symptoms deserve medical attention rather than an assumption that another episode will pass safely.
Does a hot shower resolving discomfort prove that medical care is unnecessary?
No. NIDA notes that hot showers or baths may temporarily relieve symptoms in people with CHS. Temporary comfort does not establish a diagnosis, show that the syndrome has resolved, or prove that an episode is medically safe. Seek medical assessment for recurrent vomiting, and call 911 for severe symptoms or immediate danger.
Can difficulty stopping cannabis be addressed in behavioral treatment?
Yes. NIDA identifies cognitive behavioral therapy, motivational enhancement therapy, and contingency management as approaches that can help treat cannabis use disorder. Treatment can address patterns surrounding use and the skills needed for change. Difficulty stopping deserves support, but it does not establish a diagnosis by itself or replace medical care for suspected CHS.